Bagust, A <br/><br/>
Rituximab for the treatment of rheumatoid arthritis.  [electronic resource] 

 -  Health technology assessment (Winchester, England)  Sep 2009 
 - 23-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>2046-4924 
<br/><br/><label>Standard No.: </label>10.3310/hta13suppl2/04  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--economics<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antirheumatic Agents--economics<br/>Arthritis, Rheumatoid--drug therapy<br/>Cost-Benefit Analysis<br/>Humans<br/>Quality-Adjusted Life Years<br/>Randomized Controlled Trials as Topic<br/>Rituximab